Latest Headlines
-
Research Shows New Single-Use Protein A Capture Technology Offers 10X Productivity Over Standard Resin Columns For Antibody Purification
12/14/2023
AGC Biologics launched a new research paper from its global research and development Center (R&D Center). The R&D Study reveals the promise of new, simplified downstream technology capable of harvesting volumes of 2,000 L at titers ranging up to 10 g/L purification.
-
Nordson MEDICAL Unveils Pharma+ Tubing Retainers: A Breakthrough In Fluid Transfer Efficiency
12/1/2023
Nordson MEDICAL is proud to announce the launch of Pharma+ Tubing Retainers, a revolutionary addition to their product portfolio that promises to redefine excellence in fluid transfer applications.
-
AGC Biologics To Prepare Late-Phase And Commercial Runs For Immunocore
11/19/2023
Global CDMO’s Heidelberg site to support Process Performance Qualification for IMC-F106C late-stage program and prepare for commercial readiness.
-
CPC Celebrates 10th Anniversary Of AseptiQuik® G Connectors
11/15/2023
Single-use technologies (SUT) have radically changed biopharmaceutical operations. Sterile single-use connectors are key to enabling this shift. CPC, the leader in the design and manufacture of single-use connection technologies for life sciences markets, introduced its genderless single-use AseptiQuik® G Connectors 10 years ago and continues to expand its aseptic connector portfolio.
-
Cytiva And RoosterBio Collaborate To Address Exosome Manufacturing Challenges
10/31/2023
Biotechnology leaders Cytiva and RoosterBio, Inc., are teaming up to develop a purification process to manufacture exosomes in mass quantities. This collaboration brings together the strengths of both companies to solve one of the biggest challenges currently limiting the use of exosomes as therapeutics and as delivery vehicles for gene therapies and other biologics.
-
NYBC Enterprises Acquires Commercial-Scale CGT Facilities
10/18/2023
This acquisition expands Comprehensive Cell Solutions, a business unit of NYBCe, capabilities and geographic reach as a commercial-scale cell therapy clinical development and manufacturing organization.
-
AES Recognized As The Cleanroom Provider For Two ISPE FOYA Winners
10/16/2023
Provider of high-performance cleanroom facilities for the pharmaceutical industry, AES Clean Technology, is celebrating two of its customers' success at this year's IPSE Facility of the Year Awards (FOYA), having designed and built the cleanrooms in both Genentech and Nexus Pharmaceuticals’ award-winning facilities.
-
Study Generates Public CAR-T Cell Data Using CGT Manufacturing Platforms
10/11/2023
Data will detail how the Terumo BCT’s Quantum Flex® Cell Expansion System and Finia® Fill and Finish System with BioCentriq’s LEAP™ Advanced Therapy Platform can help accelerate delivery of CAR-T therapies to patients.
-
Wheeler Bio Announces Grand Opening Of Biomanufacturing Facility
10/5/2023
Wheeler Bio, a contract development and manufacturing organization (CDMO) for next-gen protein therapeutics, announced today the grand opening of their state-of-the-art drug substance Current Good Manufacturing Practices (CGMP) facility inside the Ziggurat building (Echo Investment Capital) in Oklahoma City, OK.
-
Jennifer Manning Joins BioCentriq® As Chief Commercial Officer
10/3/2023
BioCentriq, a cell therapy CDMO, announced today the appointment of Jennifer Manning, MPA, as its Chief Commercial Officer, effective October 3, 2023.